Search | Invivogen

Human EpCAM x E. coli β-Gal Bispecific Antibody - Negative Control

Control scFv antibody - Recombinant

Evaluation of T cell activation (ELISA)

Absence of Jurkat-Lucia™ NFAT cell activation using Anti-hEpCAM-βgal

Human EpCAM x Human CD3 Bispecific Antibody

Solitomab scFv antibody - Recombinant

Evaluation of T cell activation (ELISA)

Human IL-6R (CD126) Antibody - Tocilizumab IgG1NQ Isotype

Human IgG1 Fc silent

Inhibition of IL-6R signaling by Anti-hIL6R-To-hIgG1NQ

Human IL-6R (CD126) Antibody - Tocilizumab Biosimilar

Human IgG1 - CAS#375823-41-9

Neutralization of cellular response to IL-6 using tocilizumab biosimilar

Human IL-4Rα (CD124) Antibody - Dupilumab IgG1 Isotype

Human IgG1

Neutralization of cellular response to IL-4 and IL-13 using Anti-hIL-4R-hIgG1

Mouse CD3 Antibody (clone 145-2C11)

Mouse IgG2a - For in vivo use

Validation of Anti-mCD3-mIgG2a InvivoFit™ by ELISA

Validation of Anti-mCD3-mIgG2a InvivoFit™ by FACS

Mouse CD8 Antibody (clone YTS 169.4)

Mouse IgG2a - For in vivo use

Validation of Anti-mCD8-mIgG2a binding by FACS

Validation of in vivo CD8 + T cell depletion using Anti-mCD8-mIgG2a InvivoFit™

Mouse CD4 Antibody (clone GK1.5)

Mouse IgG2a - For in vivo use

Validation of Anti-mCD4-mIgG2a binding by FACS

Validation of in vivo CD4 + T cell depletion using Anti-mCD4-mIgG2a InvivoFit™

CR3018-derived Anti SARS-CoV-2 Nucleocapsid hIgG1 antibody

Anti SARS-CoV & SARS-CoV-2 nucleocapsid antibody

Binding of Anti-CoV-N-hIgG1 to SARS-CoV-2 nucelocapsid by ELISA

B38-derived Anti-SARS-CoV2 RBD mAbs, human & mouse isotypes

Anti-SARS-CoV-2-Spike RBD antibody (Clone B38)

Validation of Anti-CoV2RBD-c2-hIgG1 binding to SARS-CoV-2 RBD by ELISA

Neutralization ability of Anti-SARS-CoV-2 Spike-RBD mAbs

Anti-CoV2RBD-c2-mIgG2a ELISA

H4-derived Anti-SARS-CoV2 RBD mAbs, human & mouse isotypes

Anti SARS-CoV-2 Spike RBD antibody

Validation of binding to SARS-CoV-2 RBD by ELISA

Validation of binding to SARS-CoV-2 spike-expressing cells

Neutralization ability of Anti-SARS-CoV-2 Spike-RBD mAbs

Anti-CoV2RBD-c1-mIgG2a ELISA

HER2 antibody for ADC (Trastuzumab biosimilar)

Human IgG1 - For antibody-drug conjugation

EL4-HER2 cell surface staining

SK-BR-3 cell surface staining

STING-ADC-mediated cell responses

TLR7-ADC-mediated cell responses

Human BCMA x Human CD3 Bispecific Antibody

Pacanalotamab scFv antibody - Recombinant

Evaluation of T cell activation

Original strain - Fc-tagged RBD Protein

Original | RBD-Fc

Spike-RBD-Fc analysis by SDS PAGE

Recognition of Spike-RBD-Fc by anAnti-SARS-CoV-Spike human IgM

Delta Variant - Luciferase-tagged RBD protein

Delta | B.1.617.2 | RBD-Lucia

RBD-LuciaV8 (B.1.617.2) for Luciferase-based ELISA

Luciferase based ELISA

Iota Variant - Luciferase-tagged RBD protein

Iota | B.1.526 | RBD-Lucia

RBD-LuciaV6 (B.1.526) for Luciferase-based ELISA

Luciferase based ELISA

Gamma Variant - Luciferase-tagged RBD protein

Gamma | P.1 | RBD-Lucia

RBD-LuciaV5 (P.1) for Luciferase-based ELISA

Luciferase based ELISA

Human CD70 Antibody - Vorsetuzumab IgG1fut Isotype

Human IgG1, afucosylated

Binding of Anti-hCD70-hIgG1fut mAb to hCD70

Comparison of ADCC induction of Anti-hCD70 mAbs

Human CD70 Antibody - Vorsetuzumab Biosimilar

Human IgG1 - CAS #1165741-01-4

Comparison of ADCC induction of Anti-hCD70 mAbs

Binding of Anti-hCD70-hIgG1 mAb to hCD70

Human IFNAR Antibody - Anifrolumab Biosimilar

Human IgG1 Fc silent - CAS #1326232-46-5

Dose-dependent inhibition of IFN-α and IFN-β signaling in HEK-Blue™ IFN-α/β cells using Anifrolumab